| Rhea Dayaday Ortiz, ACNS-BC | |
|
6624 Fannin St, Suite 2380, Houston, TX 77030-2312 | |
| (713) 800-6212 | |
| Not Available |
| Full Name | Rhea Dayaday Ortiz |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist |
| Location | 6624 Fannin St, Houston, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073661575 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364S00000X | Clinical Nurse Specialist | 612055 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rhea Dayaday Ortiz, ACNS-BC 6624 Fannin St, Suite 2380, Houston, TX 77030-2312 Ph: (713) 800-6212 | Rhea Dayaday Ortiz, ACNS-BC 6624 Fannin St, Suite 2380, Houston, TX 77030-2312 Ph: (713) 800-6212 |
News Archive
Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has expanded its plans for its United States Food and Drug Administration (FDA) Expanded Access Treatment IND Program for its flagship product, Generex Oral-lyn™, to include licensed and qualified Nurse Practitioners in the United States.
A 20-year study following 110,645 workers who helped clean up after the 1986 Chernobyl nuclear power plant accident in the former Soviet territory of Ukraine shows that the workers share a significant increased risk of developing leukemia. The results may help scientists better define cancer risk associated with low doses of radiation from medical diagnostic radiation procedures such as computed tomography scans and other sources.
RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutic discovery and development, today reported its financial results for the second quarter ended June 30, 2010.
VIA Pharmaceuticals, Inc., a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today announced that it has completed the last patient visit in its Phase 2 FDG-PET clinical trial of VIA-2291.
A study conducted by researchers at Columbia University Medical Center found that older adults who used a hearing aid performed significantly better on cognitive tests than those who did not use a hearing aid, despite having poorer hearing. The study was published online in the American Journal of Geriatric Psychiatry.
› Verified 5 days ago
Stephanie Quintero, MSN, APRN, AG CNS-BC Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 1515 Holcombe Blvd, Houston, TX 77030 Phone: 713-792-6161 | |
Amy Jean Wolford, A.P.N Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 14340 Torrey Chase Blvd, Suite 160, Houston, TX 77014 Phone: 281-580-8086 Fax: 281-580-7129 | |
Cuong Thi Thanh Phan, Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 7401 Main St, Houston, TX 77030 Phone: 713-799-2300 Fax: 713-794-3380 | |
Margaret A. Mcmartin, CNS-P/MH-LPA Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1311 Antoine Dr Apt 283, Houston, TX 77055 Phone: 713-208-0456 | |
Paula F. Demasi, RN, CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1515 Holcombe Blvd, Houston, TX 77030 Phone: 713-792-6161 | |
Martha Wimberly Oloomi, APRN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 2002 Holcombe Blvd, Sci/rehab/neuro Service Line, Houston, TX 77030 Phone: 281-980-0465 | |
Dona Marie Gambrel, APRN, BC Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 9401 Southwest Fwy, Houston, TX 77074 Phone: 713-448-6986 Fax: 713-448-5746 |